PPBT · Purple Biotech Ltd.

$1.39 +0.06 (+4.51%) At close · Jul 23

Market Cap

$1.33M

932,274

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2025-04-07	Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025	Conference
2024-07-11	Purple Biotech to host a virtual KOL event on July 11, 2024, to discuss positive interim results from the phase 2 pancreatic cancer study with CM24. Watch here.	Event
2024-06-04	Purple Biotech will present data from the Randomized Phase 2 CM24 Pancreatic Cancer Study in a Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting which takes place May 31 - June 4, 2024 in Chicago, Illinois.	Shareholder meeting
2023-04-20	Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference on April 20, 2023.	Conference
2023-03-20	Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.	Event
2023-02-06	Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.	Conference
2023-01-09	Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023	Event
2022-11-15	Purple Biotech to participate and Present at the Jefferies London Healthcare Conference	Conference
2022-11-14	Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis	Conference
2022-11-08	Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. - Click here to replay	Event
2022-06-05	Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022 annual meeting	Shareholder meeting
2022-04-08	Purple Biotech to present at the AACR annual meeting 2022	Shareholder meeting
2021-08-09	Purple Biotech to participate in a Fireside Chat at BTIG Virtual Biotechnology Conference	Conference
2021-06-04	Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting	Shareholder meeting
2021-06-04	Purple Biotech to Present at the Jefferies Virtual Healthcare Conference	Conference
2021-01-20	Purple Biotech to Present at the B. Riley Oncology Investor Conference	Conference

Key facts CIK 1614744 CUSIP 74638P307 13F (30d) 1 filings 1 filers Visit website